MULTI-001 Nivolumab v7
MULTI-002 Carboplatin and etoposide v1
MULTI-003 Pembrolizumab v7
MULTI-010 ECX v2
MULTI-011 ECF v2
MULTI-012 ECarboX v2
MULTI-013 ECarboF v2
MULTI-018 Larotrectinib v1
MULTI-019 Entrectinib v1
HNT-016 TPF v9
HNT-018 TP v3
HNT-023 Sorafenib for thyroid cancer v1
HNT-025 Carboplatin, 5-Fluorouracil and Cetuximab v2
HNT-026 Cisplatin, 5-Fluorouracil and Cetuximab v1
HNT-027 T-Carbo v1
HNT-028 Cabozantinib v1
HNT-029 Lenvatinib (LENVIMA®) for thyroid cancer v1
